PetVivo Holdings, Inc. (NASDAQ:PETV) announced the results of a clinical study conducted by Ethos Veterinary Health at the American College of Veterinary Surgeons annual conference. The study examined the benefit and tolerability of an intra-articular injection of a collagen-elastin biomaterial (Spryng™ with OsteoCushion™ Technology) into the stifle joint of dogs with suspected cruciate ligament rupture. The results demonstrated the efficacy of this product as a non-invasive alternative for patients with cranial cruciate disease.